Marc Schegerin - Sep 7, 2023 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
CFO and COO
Signature
/s/ Robert Farrell as attorney-in-fact for Marc Schegerin
Stock symbol
MORF
Transactions as of
Sep 7, 2023
Transactions value $
-$786,849
Form type
4
Date filed
9/8/2023, 07:00 PM
Previous filing
Jun 15, 2023
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $300K +20K +82.86% $15.00 44.1K Sep 7, 2023 Direct F1
transaction MORF Common Stock Sale -$356K -6.69K -15.16% $53.20 37.4K Sep 7, 2023 Direct F2, F3
transaction MORF Common Stock Sale -$731K -13.3K -35.54% $54.92 24.1K Sep 7, 2023 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -20K -25.88% $0.00 57.3K Sep 7, 2023 Common Stock 20K $15.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 396 shares of Common Stock acquired under the Issuer's employee stock purchase plan on February 28, 2022.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated June 28, 2022.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.19 to $55.10 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The option vested as to 25% of the total shares on April 6, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on April 6, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.